Royalty Pharma plc (RPRX) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
RPRX Stock Price Trajectory (2020–2026)
As of March 5, 2026, Royalty Pharma plc (RPRX) trades at $47.43, representing a +40.5% return over the past year. The stock has delivered a +2.2% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $56.50 on June 18, 2020. From this peak, RPRX has corrected -16.1%, currently trading 25% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers LGND (+81.1% 1Y), INVA (+29.1% 1Y), and BTX (-5.3% 1Y), RPRX has underperformed the peer group average. Compare RPRX vs LGND →
Historical Price Data
Showing 30 of 1,437 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-03-04 | 47.50 | 47.86 | 47.25 | 47.43 | 4.30M | -0.11% |
| 2026-03-03 | 46.88 | 47.66 | 46.44 | 47.48 | 3.72M | +0.02% |
| 2026-03-02 | 45.87 | 47.50 | 45.80 | 47.47 | 4.41M | +2.73% |
| 2026-02-27 | 45.44 | 46.37 | 45.26 | 46.21 | 4.18M | +1.87% |
| 2026-02-26 | 45.20 | 45.78 | 44.88 | 45.36 | 2.57M | +0.47% |
| 2026-02-25 | 45.13 | 45.62 | 45.01 | 45.15 | 2.82M | -0.55% |
| 2026-02-24 | 45.42 | 45.67 | 45.15 | 45.40 | 4.54M | -0.15% |
| 2026-02-23 | 45.00 | 45.68 | 44.97 | 45.47 | 2.18M | +0.78% |
| 2026-02-20 | 44.88 | 45.29 | 44.63 | 45.12 | 45 | +0.02% |
| 2026-02-19 | 45.26 | 45.27 | 44.68 | 45.11 | 1.97M | -0.51% |
| 2026-02-18 | 45.15 | 45.38 | 44.91 | 45.34 | 2.02M | -0.81% |
| 2026-02-17 | 45.38 | 46.10 | 45.19 | 45.71 | 367K | +1.15% |
| 2026-02-13 | 44.80 | 45.91 | 44.71 | 45.19 | 5.41M | +0.87% |
| 2026-02-12 | 44.24 | 45.27 | 44.05 | 44.80 | 5.71M | +1.24% |
| 2026-02-11 | 42.94 | 45.24 | 42.50 | 44.25 | 5.21M | +0.09% |
| 2026-02-10 | 44.08 | 44.26 | 43.63 | 44.21 | 3.15M | +0.36% |
| 2026-02-09 | 44.64 | 44.90 | 43.98 | 44.05 | 3.39M | -1.34% |
| 2026-02-06 | 44.31 | 44.92 | 43.95 | 44.65 | 3.54M | +1.25% |
| 2026-02-05 | 43.57 | 44.35 | 43.43 | 44.10 | 6.01M | +0.96% |
| 2026-02-04 | 43.43 | 43.76 | 43.02 | 43.68 | 5.15M | +1.65% |
| 2026-02-03 | 42.32 | 43.07 | 42.28 | 42.97 | 3.39M | +1.44% |
| 2026-02-02 | 41.52 | 42.38 | 41.46 | 42.36 | 3.86M | +1.63% |
| 2026-01-30 | 41.27 | 41.72 | 40.86 | 41.68 | 3.47M | +2.01% |
| 2026-01-29 | 40.50 | 40.91 | 40.38 | 40.86 | 3.07M | +1.11% |
| 2026-01-28 | 40.54 | 40.80 | 40.16 | 40.41 | 3.23M | -0.81% |
| 2026-01-27 | 40.50 | 40.90 | 40.49 | 40.74 | 2.76M | +0.67% |
| 2026-01-26 | 40.41 | 40.63 | 40.18 | 40.47 | 5.13M | +0.17% |
| 2026-01-24 | 40.09 | 40.57 | 39.96 | 40.40 | 2.25M | 0.00% |
| 2026-01-23 | 40.09 | 40.57 | 39.96 | 40.40 | 3.53M | +0.72% |
| 2026-01-22 | 39.77 | 40.12 | 39.62 | 40.11 | 4.99M | +0.98% |
See RPRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RPRX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare RPRX vs LLY
See how RPRX stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
How has RPRX stock performed recently?
RPRX returned +40.5% over the past year, beating its 5-year annualized CAGR of +2.2%. The stock trades above its 200-day moving average, confirming the uptrend.
What is RPRX's all-time high price?
Royalty Pharma plc reached $56.50 on 2020-06-18. The 52-week high is $47.86. Current 1-year return of +40.5% places the stock closer to historical peaks.
Where can I download RPRX historical price data?
This page provides RPRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.